Insider Buying and Selling - XENE

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
09/30/2026	10/01/2026	Kelly Thomas Patrick Chief Financial Officer CFO	Buy	15,000 @ $37.32	$559,740.00	15,000	(100.00%)	Direct
09/30/2026	10/01/2026	Mortimer Ian PRESIDENT & CEO CEO Director	Buy	30,000 @ $37.38	$1,121,400.00	49,923	(150.58%)	Direct
08/28/2026 10b5-1	08/31/2026	Kenney Christopher John Chief Medical Officer Officer	Sell	-7,068 @ $60.25	($425,828.99)	2	(-99.97%)	Direct
08/11/2026	08/13/2026	Gannon Steven Director	Sell	-10,000 @ $64.06	($640,550.00)	1,870	(-84.25%)	Direct
06/05/2026 10b5-1	06/08/2026	Cannon Gillian Director	Sell	-1,190 @ $53.14	($63,236.60)	1,455	(-44.99%)	Direct
06/05/2026 10b5-1	06/08/2026	Patou Gary Director	Sell	-1,322 @ $53.14	($70,251.08)	24,896	(-5.04%)	Direct
12/08/2025 10b5-1	12/09/2025	Mortimer Ian PRESIDENT & CEO CEO Director	Sell	-10,830 @ $45.73	($495,207.00)	6,000	(-64.35%)	Direct
12/05/2025 10b5-1	12/09/2025	Mortimer Ian PRESIDENT & CEO CEO Director	Sell	-14,375 @ $45.03	($647,306.25)	16,830	(-46.07%)	Direct
11/28/2025 10b5-1	12/03/2025	Mortimer Ian PRESIDENT & CEO CEO Director	Sell	-97 @ $45.01	($4,365.97)	31,205	(-0.31%)	Direct

Xenon Pharmaceuticals Inc. - XENE